We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Women Satisfied With Contralateral Mastectomy

By HospiMedica staff writers
Posted on 09 Nov 2005
Ten years after having a contralateral prophylactic mastectomy (CPM), most women reported they are satisfied and would elect the procedure again.

Following diagnosis of breast cancer, a woman has around a 15% chance of developing cancer in the other breast. More...
In women with BRCA mutations, the risk increases to 52% over a lifetime, and for women under 40 at diagnosis, the risk is 40% within the first 10 years. To manage these risks, women may have more-frequent screenings, take chemotherapy, have a preventive removal of ovaries, or have a mastectomy of the other breast.

More than 80% of the 583 women in the study reported satisfaction with their decision, although that depended on the type of surgery. Those women who had a subcutaneous mastectomy, with about 95% of breast tissue removed, reported more problems with reconstruction, and fewer were satisfied with the procedure than those women who had a simple mastectomy with only breast tissue and nipple removed. Satisfaction levels were higher (83%) on average in women who had a single prophylactic mastectomy, compared to women who had bilateral (both breasts) prophylactic mastectomies (70%).

Among the adverse psychologic and social outcomes were negative feelings toward body appearance (33%), loss of sense of femininity (26%), negative impact on sexual relationships (23%), added stress (17%), decrease in self-esteem (17%), and decrease in emotional stability (12%).

"Clearly, a woman diagnosed with a first breast cancer who has a family history of breast cancer is faced with complex decisions about the treatment of her cancer and her risk for cancer in the other breast,” said lead investigator Marlene Frost, Ph.D., an oncology researcher at Mayo Clinic (Rochester, MN, USA). "It is important that these women have information about the probable effectiveness, as well as psychological and social outcomes, of their options.”




Related Links:
Mayo Clinic

Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical Examination & Procedure Light
Vega 80
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.